This website isn’t supported by Internet Explorer. We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.

For healthcare professionals only

You are viewing the Novo Nordisk Virtual platform, provided to non-US health care professionals from around the world. By accessing this site and materials you accept this legal notice and expressly confirm your status as a healthcare professional.


This site is not country-specific and therefore may contain information which is not applicable to your country. Therefore, before prescribing any product, always refer to local materials such as the prescribing information and/or the Summary of Product Characteristics.


This site is not intended to provide medical advice and/or treatment guidance. Novo Nordisk accepts no liability for the accuracy, completeness or use of the information, and disclaims any liability to update the information contained on this site.

I hereby declare I am a non-US health care professional and that I have read and agreed to the terms mentioned above.

Scroll down

ASCVD and type 2 diabetes

Atherosclerosis is the predominant cause of CVD and death in people with type 2 diabetes. Hence, it is crucial to identify and treat people with type 2 diabetes and long-term atherosclerotic CVD risk early.
Patient Engagement Platform

Comorbid cardiovascular disease and diabetes can raise patient concerns and present particular management challenges. can help answer patient questions, giving you more time to focus on their treatment.
Obesity and CVD

Explore a series of articles covering the link between obesity and cardiovascular disease (CVD), the global burden of CVD and the residual CVD risk rising from obesity.

A century of breakthroughs in health has shown us that progress is only made possible by driving change. As Novo Nordisk turns 100, we renew our commitment to drive change for a healthy world today, and for generations to come.

We invite you to explore our heritage and the legacy of our founders which have characterised our past and will define our future.